Alz-50 and ubiquitin immunoreactivity is induced by permanent focal cerebral ischaemia in the cat
- PMID: 8310818
- DOI: 10.1007/BF00294302
Alz-50 and ubiquitin immunoreactivity is induced by permanent focal cerebral ischaemia in the cat
Abstract
The effects of permanent focal cerebral ischaemia on Alz-50 and ubiquitin antibody immunohistochemical staining were investigated in vivo in the cat. Alz-50 and ubiquitin antibody staining was compared to the distribution of ischaemic cell damage. Six hours following permanent occlusion of one middle cerebral artery, Alz-50 immunoreactivity was present in neurones in the ipsilateral ischaemic cerebral cortex and caudate nucleus but not in any region of the contralateral hemisphere or in sham-operated cats. Only a proportion of neurones were stained with Alz-50 and these did not have the shrunken, pyknotic appearance characteristic of irreversible ischaemic cell damage. Ubiquitin immunoreactivity was also increased in the ischaemic hemisphere, again only a proportion of neurones were stained. The Alz-50 antibody recognises the microtubule-associated protein tau and stains neurofibrillary tangles as well as neurones vulnerable to neurofibrillary change in tissue sections of Alzheimer brain. The results indicate that there are changes in tau protein in response to an ischaemic insult, but only in some neurones, which may reflect an early stage of the degenerative process. Increased ubiquitin immunoreactivity may be a response to the presence of abnormal proteins, including tau, which are induced by an ischaemic challenge.
Similar articles
-
Cerebral ischemia induces alterations in tau and ubiquitin proteins.Dementia. 1994 May-Aug;5(3-4):168-73. doi: 10.1159/000106716. Dementia. 1994. PMID: 8087173
-
Widespread appearance of Alz-50 immunoreactive neurons in the human brain with cerebral infarction.Stroke. 1995 Nov;26(11):2145-8. doi: 10.1161/01.str.26.11.2145. Stroke. 1995. PMID: 7482663
-
Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies.J Neuropathol Exp Neurol. 1988 Jul;47(4):393-405. doi: 10.1097/00005072-198807000-00001. J Neuropathol Exp Neurol. 1988. PMID: 2838588
-
Expression of p53 and ALZ-50 immunoreactivity in rat cortex: effect of prenatal exposure to ethanol.Exp Neurol. 1998 Dec;154(2):418-29. doi: 10.1006/exnr.1998.6907. Exp Neurol. 1998. PMID: 9878179
-
Alz 50 as a reagent to assess animal models of Alzheimer's disease.Neurobiol Aging. 1992 Sep-Oct;13(5):613-4. doi: 10.1016/0197-4580(92)90066-7. Neurobiol Aging. 1992. PMID: 1461351 Review.
Cited by
-
Tau Protein Dysfunction after Brain Ischemia.J Alzheimers Dis. 2018;66(2):429-437. doi: 10.3233/JAD-180772. J Alzheimers Dis. 2018. PMID: 30282370 Free PMC article. Review.
-
Commentary on "a roadmap for the prevention of dementia II. Leon Thal Symposium 2008." Rationale and recommendations for first evaluating anti-Alzheimer's disease medications in acute brain injury patients.Alzheimers Dement. 2009 Mar;5(2):143-6. doi: 10.1016/j.jalz.2009.01.013. Alzheimers Dement. 2009. PMID: 19328446 Free PMC article. No abstract available.
-
Proteomic and Genomic Changes in Tau Protein, Which Are Associated with Alzheimer's Disease after Ischemia-Reperfusion Brain Injury.Int J Mol Sci. 2020 Jan 30;21(3):892. doi: 10.3390/ijms21030892. Int J Mol Sci. 2020. PMID: 32019137 Free PMC article. Review.
-
Acetylated Tau Protein: A New Piece in the Puzzle between Brain Ischemia and Alzheimer's Disease.Int J Mol Sci. 2022 Aug 16;23(16):9174. doi: 10.3390/ijms23169174. Int J Mol Sci. 2022. PMID: 36012440 Free PMC article.
-
The potential for estrogens in preventing Alzheimer's disease and vascular dementia.Ther Adv Neurol Disord. 2009 Jan;2(1):31-49. doi: 10.1177/1756285608100427. Ther Adv Neurol Disord. 2009. PMID: 19890493 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Miscellaneous